Validating the accuracy of a multifunctional smartwatch sphygmomanometer to monitor blood pressure
Li YI1
Zhong-Hua LV2
Shun-Ying HU3
Yu-Qi LIU3
Jia-Bing YAN4
Hui Zhang4
Hong-Bao LI4
Qin CHEN4
Yue-Yang LI3
Yu-Fan JIANG5
Hao ZHOU5
Mu-Ding LI5
Run-Du CHEN5
Xiao-Long LI2
Shan-Shan ZHOU3
Yun-Dai CHEN3
1.Department of Cardiology,the First Medical Centre,Chinese PLA General Hospital,Beijing,China2.Department of Cardiology,the Sixth Medical Centre,Chinese PLA General Hospital,Beijing,China;Medical School of Chinese PLA,Beijing,China3.Department of Cardiology,the First Medical Centre,Chinese PLA General Hospital,Beijing,China;Department of Cardiology,the Sixth Medical Centre,Chinese PLA General Hospital,Beijing,China4.Huawei Device Co.,Ltd.,Shenzhen,China5.Medical School of Chinese PLA,Beijing,China
摘要：BACKGROUND Hypertension is the most modifiable factor associated with cardiovascular events and complications. The conventional blood pressure (BP) meter method is simple but is limited in terms of real-time monitoring abnormal BP. Therefore, the development of a multifunction smartwatch (HUAWEI WATCH D) sphygmomanometer could significantly improve integ-rated BP monitoring.METHODS We enrolled 361 subjects from Chinese PLA General Hospital, Beijing, China to validate the accuracy of the smart-watch versatile sphygmomanometer using ISO 81060-2:2018. Resting and ambulatory BP accuracy of the smartwatch were com-pared with gold standard clinical sphygmomanometers using ISO 81060-2:2018 guidelines, the accuracy of 24 h systolic blood pressure (SBP) circadian rhythm monitoring, and diurnal high SBP alert for this smartwatch were assessed using a confusion matrix approach. Additionally, we analyzed online users of different ages for compliance. RESULTS Eighty-five subjects underwent resting BP measurements; the mean resting BP differences between two devices were ?0.683 ± 6.203 mmHg (SBP) (P = 0.723) and 1.628 ± 5.028 mmHg (diastolic blood pressure, DBP) (P = 0.183). In 35 subjects' ambulatory BP measurements, the mean differences of ambulatory BP were ?1.943 ± 5.475 mmHg (SBP) (P = 0.923) and 3.195 ± 5.862 mmHg (DBP) (P = 0.065). All data complied with ISO 81060-2:2018 guidelines (mean ≤ ±5 mmHg and standard deviation ≤±8 mmHg) with no significant differences. Positive predictive values (PPV) of resting SBP and DBP were 0.635 and 0.671, respect-ively. The PPV of ambulatory SBP and DBP were 0.686. Also, 24 h SBP circadian rhythm monitoring was performed in 107 sub-jects: accuracy = 0.850, specificity = 0.864, precision/PPV= 0.833, sensitivity = 0.833, and F1-measure (F1) = 0.833. The accuracy, specificity, precision, sensitivity, and F1 values in 85 subjects undergoing diurnal high SBP alerting were 0.858, 0.876, 0.706, 0.809, and 0.754, respectively. CONCLUSIONS When compared with the gold standard clinical sphygmomanometer, smartwatch results were consistent and accurate. Online user feedback showed that elderly individuals cared more about BP monitoring accuracy, with better compli-ance.
机标关键词：pressuremonitormanobloodaccuracymultifunctionalomansmartwatch
论文发表日期：2022-11-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：10( 843-852 )